|
[Related PubMed/MEDLINE]
Total Number of Papers: 222
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Formulation strategy of nitrofurantoin: co-crystal or solid dispersion? |
ATR-FTIR, DSC, HPMC, NF |
| 2 |
2020 |
Preparation and evaluation of a novel solid dispersion using leucine as carrier. |
Leu, OA |
| 3 |
2020 |
Solubilization of phloretin via steviol glycoside-based solid dispersion and micelles. |
MC, PT, SA, STE |
| 4 |
2019 |
Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats. |
BA, CXB, DW, SLS |
| 5 |
2019 |
Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects. |
BA, MDCK line, PTX, TPGS |
| 6 |
2019 |
Design of Coenzyme Q10 solid dispersion for improved solubilization and stability. |
CQ10 |
| 7 |
2019 |
Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization. |
BCRP, DSC, FTIR, SEM, XRPD |
| 8 |
2019 |
Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide. |
FLT, MDSC, PM, PXRD |
| 9 |
2019 |
Effect of Carrier Lipophilicity and Preparation Method on the Properties of Andrographolide⁻Solid Dispersion. |
AG, PEG, Tm |
| 10 |
2019 |
Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies. |
ARI, DSC, HME, SA, SEM, XRD |
| 11 |
2019 |
Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation. |
AGJ, AIJ, HK, PLX |
| 12 |
2019 |
Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process. |
AUC, CSE, SAS |
| 13 |
2019 |
Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide. |
DTA, HPMC, MLX, NC, PXRD, SEM |
| 14 |
2019 |
Insight into the Dissolution Molecular Mechanism of Ternary Solid Dispersions by Combined Experiments and Molecular Simulations. |
DSC, GLI, IR, MD, SEM, XRD |
| 15 |
2019 |
Naftopidil-fumaric acid interaction in a solid dispersion system: Improving the dissolution rate and oral absorption of naftopidil in rats. |
NAF |
| 16 |
2019 |
Predicting physical stability of solid dispersions by machine learning techniques. |
ED, RF |
| 17 |
2019 |
Preparation of Liquid Oral Mucoadhesive Gastro-retentive System of Nimodipine. |
--- |
| 18 |
2019 |
Preparation, characterization and ex vivo-in vivo assessment of candesartan cilexetil nanocrystals via solid dispersion technique using an alkaline esterase activator carrier. |
CC |
| 19 |
2019 |
Preparation, physicochemical and pharmacological study of curcumin solid dispersion with an arabinogalactan complexation agent. |
AG, CUR, GPC |
| 20 |
2019 |
Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment. |
AUC, DSC, FTIR, KPF, SEM, XRD |
| 21 |
2019 |
Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. |
H-bond, HME, LPV, P-gp |
| 22 |
2019 |
T2 Relaxation Study to Evaluate the Crystalline State of Indomethacin Containing Solid Dispersions Using Time-Domain NMR. |
APIs, IMC, PM, PVP, TD-NMR |
| 23 |
2019 |
Ternary solid dispersion to improve solubility and dissolution of meloxicam. |
HPMC, MLX, NA |
| 24 |
2018 |
Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability. |
DSC, PXRD, SEM |
| 25 |
2018 |
Association of Silver Nanoparticles and Curcumin Solid Dispersion: Antimicrobial and Antioxidant Properties. |
CUR |
| 26 |
2018 |
Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin. |
CUR, HPMC K4M, PVP-K30 |
| 27 |
2018 |
Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions. |
AUCs, FTIR, PZQ, SDS, XRD |
| 28 |
2018 |
Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation. |
CETP, SMEDDS |
| 29 |
2018 |
Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug. |
SDSLs, SLs |
| 30 |
2018 |
Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions. |
ASDs, AUC, BNZ, PCZ |
| 31 |
2018 |
Enhancement of Aqueous Solubility and Dissolution of Celecoxib through Phosphatidylcholine-Based Dispersion Systems Solidified with Adsorbent Carriers. |
CLC, FT-IR, PC |
| 32 |
2018 |
Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery system. |
SMEDDS |
| 33 |
2018 |
HPMCAS as an effective precipitation inhibitor in amorphous solid dispersions of the poorly soluble drug candesartan cilexetil. |
CC, HPMC, HPMCAS |
| 34 |
2018 |
Identification of molecular-interaction sites between lowly hydrolyzed polyvinyl alcohols and indomethacin by NMR spectroscopy. |
IND, NOESY, PVAs |
| 35 |
2018 |
Molecular-level elucidation of saccharin-assisted rapid dissolution and high supersaturation level of drug from Eudragit E solid dispersion. |
EUD-E, PHT, SAC |
| 36 |
2018 |
Preparation and comparison of tacrolimus-loaded solid dispersion and self-microemulsifying drug delivery system by in vitro/in vivo evaluation. |
HPMC, SMEDDS |
| 37 |
2018 |
Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. |
CUR |
| 38 |
2018 |
Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement. |
DSC, DT, HME, LB, PXRD, SEM, SRE |
| 39 |
2018 |
Preparation, characterization and in vitro and in vivo evaluation of a solid dispersion of Naringin. |
FT-IR, NA |
| 40 |
2018 |
Solid dispersion of dutasteride using the solvent evaporation method: Approaches to improve dissolution rate and oral bioavailability in rats. |
ATR FT-IR, BA, DSC, DUT, FESEM, MCC, PXRD, SLS, TPGS |
| 41 |
2018 |
Solid dispersions to enhance the delivery of a potential drug candidate LPSF/FZ4 for the treatment of schistosomiasis. |
--- |
| 42 |
2018 |
Synchronized release of bufadienolides in a stable Lutrol F127 based solid dispersion prepared with spray congealing. |
--- |
| 43 |
2017 |
Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium. |
FDC, MgO, PEG 6000, PRA, TEL |
| 44 |
2017 |
Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate. |
BCS, DW, FT-IR, SLS, TDF |
| 45 |
2017 |
Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions. |
DSC, MLX, ODTs, PVP k30, SLS, XRD |
| 46 |
2017 |
Development of a binary carrier system consisting polyethylene glycol 4000 - ethyl cellulose for ibuprofen solid dispersion. |
API, ATR-FTIR, DSC, EC, PEG, SDP, SEM |
| 47 |
2017 |
Development, Physicochemical Characterization and In Vitro Anti-Inflammatory Activity of Solid Dispersions of alpha,beta Amyrin Isolated from Protium Oilresin. |
ABAM, DSC, FTIR, HPMC, KND, PM, RE, SEM, TG, XRD |
| 48 |
2017 |
Enhancement of solubility and dissolution rate of baicalein, wogonin and oroxylin A extracted from Radix scutellariae. |
VC |
| 49 |
2017 |
Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions. |
DSC, FTIR, PXRD, RTV, SEM |
| 50 |
2017 |
Ginger Extract-Loaded Solid Dispersion System with Enhanced Oral Absorption and Antihypothermic Action. |
GE, GE |
| 51 |
2017 |
Improved Dissolution of Dipyridamole with the Combination of pH-Modifier and Solid Dispersion Technology. |
DP, TA |
| 52 |
2017 |
Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design. |
SDnisol |
| 53 |
2017 |
Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir. |
DoE, DRV |
| 54 |
2017 |
Surface Solid Dispersion and Solid Dispersion of Meloxicam: Comparison and Product Development. |
CPV, MLX, SSD |
| 55 |
2017 |
Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats. |
BA, TDF |
| 56 |
2016 |
A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug. |
DL, FEN, PF127 |
| 57 |
2016 |
A silica-supported solid dispersion of bifendate using supercritical carbon dioxide method with enhanced dissolution rate and oral bioavailability. |
DSC, RH, XRD |
| 58 |
2016 |
Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant. |
EOP, HME |
| 59 |
2016 |
Atorvastatin solid dispersion for bioavailability enhancement. |
AT |
| 60 |
2016 |
Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. |
ATR-FTIR, DSC, ITZ, PXRD |
| 61 |
2016 |
Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. |
CS, NIMs, NPs |
| 62 |
2016 |
Development and evaluation of solid dispersion of spironolactone using fusion method. |
API, PEG 4000, SPL |
| 63 |
2016 |
Development and Optimization of Controlled Porosity Osmotic Tablets of Lamotrigine Solid Dispersion. |
CPOT |
| 64 |
2016 |
Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution. |
--- |
| 65 |
2016 |
Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate. |
--- |
| 66 |
2016 |
Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersions. |
ATV, DSC, EZT, PMs, PXRD, TC |
| 67 |
2016 |
Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations. |
HME, PMs, SIM |
| 68 |
2016 |
Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability. |
beta-CD, DSC, ESL, FTIR, ODT, XRD |
| 69 |
2016 |
Hydrophilic-hydrophobic polymer blend for modulation of crystalline changes and molecular interactions in solid dispersion. |
--- |
| 70 |
2016 |
Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate. |
HPMC, SLS |
| 71 |
2016 |
Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion. |
--- |
| 72 |
2016 |
Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment. |
ODF |
| 73 |
2016 |
Physical characterization and dissolution performance assessment of Etravirine solid dispersions prepared by spray drying process. |
ANOVA, DSC, FTIR, MDT, SEM |
| 74 |
2016 |
Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight. |
DPL, HPMC, PVP |
| 75 |
2016 |
Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs. |
SA, TEL |
| 76 |
2016 |
Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions. |
FEL, SOL |
| 77 |
2016 |
Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers. |
CRSP, DSC, FTIR, SEM, SLS, XRD |
| 78 |
2016 |
The improved dissolution performance of a post processing treated spray-dried crystalline solid dispersion of poorly soluble drugs. |
PVA |
| 79 |
2015 |
A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability. |
--- |
| 80 |
2015 |
Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen. |
EGE, NAP, Tg |
| 81 |
2015 |
Controlled porosity solubility modulated osmotic pump tablets of gliclazide. |
CPOP, GLZ, HME |
| 82 |
2015 |
Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin US2. |
--- |
| 83 |
2015 |
Design of modified xanthan mini-matrices for monitoring oral discharge of highly soluble Soluplus-glibenclamide dispersion. |
--- |
| 84 |
2015 |
Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance. |
AFM, ARTM, DSC, LUMF, TGA, XRD |
| 85 |
2015 |
Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches. |
DSC, PXRD, SEM |
| 86 |
2015 |
Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs. |
CR, DSC, HPMC, PRX, SEM, XPRD |
| 87 |
2015 |
Enhancement of docetaxel solubility using binary and ternary solid dispersion systems. |
DSC, DTX, FTIR, PXRD, SEM |
| 88 |
2015 |
Improvement in antiproliferative activity of Angelica gigas Nakai by solid dispersion formation via hot-melt extrusion and induction of cell cycle arrest and apoptosis in HeLa cells. |
AGN, HME |
| 89 |
2015 |
Influence of formulation technique on acrylate methacrylate copolymer modified paracetamol matrix tablets. |
DG |
| 90 |
2015 |
Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability. |
S-SMEDDS, S-SNEDDS |
| 91 |
2015 |
Investigation of the solubility enhancement mechanism of rebaudioside D using a solid dispersion technique with potassium sorbate as a carrier. |
FT-IR, PM, Reb, SEM, XRD |
| 92 |
2015 |
Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan. |
--- |
| 93 |
2015 |
Molecular interaction between glimepiride and Soluplus-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies. |
BCS, DSC, FTIR, PEG |
| 94 |
2015 |
Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system. |
BNZ, L-HPC |
| 95 |
2015 |
Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations. |
DSC, FTIR, TS, XRD |
| 96 |
2015 |
Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers. |
ALG, CS, FXD, ODTs |
| 97 |
2015 |
Physicochemical characterization and pharmacological evaluation of ezetimibe-PVP K30 solid dispersions in hyperlipidemic rats. |
DSC, EZT, PXRD, TC |
| 98 |
2015 |
Poloxamer-based curcumin solid dispersions for ex tempore preparation of supersaturated solutions intended for antimicrobial photodynamic therapy. |
PIs |
| 99 |
2015 |
Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension. |
HPMC, IND, PVP, SP |
| 100 |
2015 |
Potential use of phospholipids in combination with hydrophilic carriers for enhancement of the dissolution and oral bioavailability of imidazole antifungal Class II drugs. |
DMPG, DSC, KET, PXRD, SEM |
|
A Search Service for Abbreviation / Long Form
